| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.52B | 43.03B | 35.66B | 36.26B | 32.79B | 32.46B |
| Gross Profit | 36.52B | 37.07B | 33.80B | 35.49B | 31.97B | 32.00B |
| EBITDA | 5.27B | 8.93B | 6.61B | 4.63B | 4.09B | 6.74B |
| Net Income | 4.45B | 6.67B | 4.10B | 2.19B | 2.10B | 4.23B |
Balance Sheet | ||||||
| Total Assets | 2.89T | 2.84T | 2.89T | 2.85T | 2.77T | 2.96T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 164.61B | 307.35B | 351.61B | 334.87B | 524.84B |
| Total Debt | 155.30B | 166.30B | 143.30B | 138.30B | 128.30B | 369.00B |
| Total Liabilities | 2.79T | 2.73T | 2.80T | 2.76T | 2.68T | 2.86T |
| Stockholders Equity | 98.14B | 105.85B | 91.75B | 97.14B | 91.02B | 104.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.60B | -9.17B | 0.00 | -263.47B | 218.45B |
| Operating Cash Flow | 0.00 | 19.15B | -8.80B | 0.00 | -261.93B | 220.00B |
| Investing Cash Flow | 0.00 | -94.59B | -86.31B | 18.44B | 59.37B | -34.66B |
| Financing Cash Flow | 0.00 | -69.08B | 39.01B | -464.00M | -431.00M | -424.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥75.56B | 10.48 | ― | 2.34% | 3.68% | 26.06% | |
70 Outperform | ¥44.24B | 10.24 | ― | 3.28% | 17.02% | 10.99% | |
69 Neutral | ¥134.90B | 40.14 | ― | 0.58% | 24.02% | 5.60% | |
68 Neutral | ¥50.34B | 7.54 | ― | 1.20% | 30.84% | 60.48% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | ¥98.61B | 11.87 | ― | 2.12% | 37.01% | ― | |
58 Neutral | ¥45.44B | -1.87 | ― | 2.87% | 26.62% | -660.86% |